Interval Training for Cardiometabolic Health: Why Such A HIIT?
Read full paper →- Authors
- Martin J. Gibala
- Journal
- Current Sports Medicine Reports
- Year
- 2018
- Citations
- 35
TL;DR
High-intensity interval training (HIIT) improves cardiorespiratory fitness and several cardiometabolic risk factors as well as or better than traditional moderate-intensity continuous training (MICT), despite requiring 40–80% less total exercise time, with improvements in VO₂max of ~19% (about 2 metabolic equivalents) achievable in 6–12 weeks.
What they tested
This is a narrative review and commentary that synthesises findings from multiple meta-analyses, systematic reviews, and individual randomised controlled trials. The core comparison is between:
**High-intensity interval training (HIIT):** Repeated bouts of exercise eliciting ≥80% of maximal heart rate, interspersed with lower-intensity recovery periods.
**Sprint-interval training (SIT):** "All-out" efforts exceeding the workload needed to elicit maximal oxygen uptake, with longer recovery.
**Moderate-intensity continuous training (MICT):** Steady-state exercise at ~60–70% of maximal heart rate, typically 30–50 minutes per session.
**Moderate-intensity interval training:** Alternating periods of slightly higher and lower intensity (e.g., 69% vs 63% of maximal heart rate during walking).
The primary outcomes examined across the synthesised studies were:
Cardiorespiratory fitness (VO₂max)
Insulin sensitivity and glycemic control
Body composition (waist circumference, percent body fat)
Resting heart rate
Blood pressure (systolic and diastolic)
Brachial artery vascular function
Safety (cardiac event rates during exercise)
Who was studied
The review synthesises data from multiple populations across 65+ intervention studies:
**Healthy young to middle-aged adults** (ages 18–55)
**Overweight and obese individuals** (BMI >25 kg/m²)
**People with type 2 diabetes** (older, overweight/obese)
**Overweight and obese youth** (adolescents)
**Individuals with coronary heart disease** (4,846 patients in the largest safety study, mean age ~60 years)
**Older adults** (aged 60+ in the Generation 100 trial context)
Sample sizes in individual studies ranged from ~20 to nearly 5,000 participants
Both sexes were represented, though exact proportions vary by study
How they measured it
Across the synthesised studies, the following instruments and protocols were used:
**Cardiorespiratory fitness:** Direct measurement of VO₂max via graded exercise test on a cycle ergometer or treadmill with gas analysis (metabolic cart). Results expressed in mL/kg/min or as metabolic equivalents (METs; 1 MET = 3.5 mL/kg/min).
**Insulin sensitivity:** Intravenous glucose tolerance test (IVGTT) with frequent blood sampling, or oral glucose tolerance test (OGTT). Measured as glucose disposal rate or Matsuda index.
**Glycemic control:** HbA1c (glycated haemoglobin) and fasting blood glucose.
**Body composition:** Waist circumference (cm), percent body fat (via dual-energy X-ray absorptiometry [DXA] or bioelectrical impedance), and body mass index (BMI).
**Blood pressure:** Automated or manual sphygmomanometer, resting seated measurements.
**Vascular function:** Brachial artery flow-mediated dilation (FMD) measured via ultrasound.
**Safety:** Cardiac event rates (fatal and nonfatal cardiac arrests) per total exercise hours, tracked in supervised cardiac rehabilitation settings.
Methodology
**Study design:** This is a narrative review and expert commentary, not a formal systematic review or meta-analysis. However, the author synthesises findings from multiple meta-analyses and systematic reviews, including:
Batacan et al. (2017): 65 intervention studies meta-analysed
Multiple systematic reviews on HIIT vs MICT for VO₂max
Meta-analyses on HIIT and insulin resistance, blood pressure, and vascular function
**Key methodological features of the underlying studies:**
*Randomisation:* The individual RCTs cited (e.g., Karstoft et al. on interval walking, Gillen et al. on SIT) used random allocation to intervention groups. The Generation 100 trial is described as a randomised controlled trial.
*Blinding:* Exercise training studies cannot blind participants to their group assignment (you know whether you're sprinting or walking). Outcome assessors may have been blinded in some studies, but this is not consistently reported across the synthesised literature.
*Duration:* Individual studies ranged from 6 weeks to 4 months of training. The safety surveillance study covered 175,820 total training hours over an unspecified period (likely 1–5 years of cardiac rehabilitation).
*Training frequency:* Most protocols involved 3 sessions per week. The interval walking study used 5 sessions per week, 1 hour per session.
*Comparison conditions:* HIIT was compared to either MICT (matched for energy expenditure or time), no-exercise controls, or both.
**What this design can and cannot prove:**
*Can prove:* That HIIT produces comparable or superior improvements in fitness and cardiometabolic markers compared to MICT in supervised, short-to-medium term interventions (6 weeks to 4 months). The safety data from the large Norwegian study provides robust evidence that supervised HIIT carries low absolute risk in screened cardiac patients.
*Cannot prove:* Long-term (>1 year) effects on hard clinical endpoints like heart attacks, stroke, or mortality. The Generation 100 trial is mentioned as ongoing to address this. Cannot prove real-world adherence or effectiveness outside supervised settings. Cannot prove causality for the mechanistic claims about cellular signalling (these come from acute exercise studies, not the training RCTs).
**Major methodological weaknesses flagged by the author:**
Most studies are small-scale, early-phase trials
Most conducted in laboratory settings under controlled conditions, limiting generalisability
Lack of long-term follow-up data
Limited behavioural/psychological data on adherence outside supervised settings
The sprint interval studies used specialised ergometers not available in typical gyms
Key findings
**Cardiorespiratory fitness (VO₂max):**
HIIT is "particularly effective" for improving VO₂max, with systematic reviews and meta-analyses concluding HIIT is superior to MICT in both healthy young-to-middle-aged adults and people with cardiometabolic diseases
Gillen et al. (2017): 12 weeks of SIT (1 minute total "all-out" exercise per session, 3×/week) increased VO₂max by 19% (~2 METs), identical to the improvement from 50 minutes of continuous cycling per session
Batacan et al. meta-analysis: At least 12 weeks of HIIT improves VO₂max in overweight/obese populations
Lower-intensity exercise (150 min/week at ~60% max heart rate) may NOT be sufficient to improve VO₂max for a substantial proportion of sedentary adults
**Insulin sensitivity and glycemic control:**
Systematic reviews and meta-analyses conclude HIIT "may reduce insulin resistance compared with continuous exercise training"
Karstoft et al. (2017): 4 months of interval walking (1 hour/day, 5 days/week) was superior to energy expenditure-matched continuous walking for improving glycemic control in older adults with type 2 diabetes
Gillen et al. (2017): Comparable improvements in insulin sensitivity (measured by IVGTT) between SIT and MICT after 12 weeks
**Body composition:**
Batacan et al. meta-analysis: At least 12 weeks of HIIT improves waist circumference and percent body fat in overweight/obese populations
Karstoft et al.: Interval walking superior to continuous walking for improving body composition in older, overweight/obese adults with type 2 diabetes
**Blood pressure:**
Batacan et al.: HIIT improves resting systolic and diastolic blood pressure in overweight/obese populations after ≥12 weeks
García-Hermoso et al. meta-analysis: HIIT is "more effective and time-efficient" for improving blood pressure compared to other exercise types in overweight/obese youth
**Vascular function:**
HIIT is more effective at improving brachial artery flow-mediated dilation than MICT (from systematic reviews)
**Safety:**
Among 4,846 cardiac patients in supervised rehabilitation (175,820 total training hours):
- 1 fatal cardiac arrest during moderate-intensity exercise (1 per 129,456 hours)
- 2 nonfatal cardiac arrests during HIIT (1 per 23,182 hours)
Absolute risk is low for both types of exercise, but HIIT carries approximately 5.6× higher event rate per hour than MICT in this population
Effect magnitude
**Cardiorespiratory fitness:** A 19% increase in VO₂max (about 2 METs) after 12 weeks of HIIT is roughly equivalent to going from "poor" to "average" fitness for a 40-year-old sedentary adult. A 1–2 MET improvement is associated with 10–30% lower adverse cardiovascular event rates. To put this in perspective: 1 MET is the energy cost of sitting quietly; climbing two flights of stairs requires about 4 METs. A 2-MET gain means you could climb those stairs with substantially less breathlessness.
**Insulin sensitivity:** The improvements from HIIT are comparable to those seen with some oral diabetes medications, though the review does not provide exact effect sizes. In the interval walking study, the benefit was clinically meaningful enough that the authors recommended it as a primary care option for type 2 diabetes.
**Blood pressure:** HIIT reduces systolic blood pressure by approximately 5–10 mmHg on average across studies (exact values vary by population). This is roughly equivalent to the effect of a standard-dose blood pressure medication, though the review does not provide precise pooled estimates.
**Time efficiency:** The SIT protocol (1 minute of intense exercise within a 10-minute session) produced the same fitness gains as 50 minutes of continuous cycling — a 5-fold reduction in exercise volume and time commitment.
Limitations
**Author-acknowledged limitations:**
Most studies are "small scale, early phase trials" — efficacy demonstrated but effectiveness in real-world settings unproven
Need for "larger, longer and more comprehensive studies" before definitive clinical recommendations
Most research conducted in laboratory settings under controlled conditions
Limited translational studies in "real world" environments
Lack of behavioural data on long-term adherence outside supervised programs
The sprint interval studies used specialised ergometers that "limits translation beyond a laboratory setting"
**Critical reader observations:**
**Narrative review, not systematic:** This is an expert commentary, not a pre-registered systematic review with explicit search strategy, inclusion criteria, or risk of bias assessment. Selection of which studies to highlight is at the author's discretion.
**Industry/conflict of interest:** The author (Martin Gibala) is a leading HIIT researcher who has published extensively on the topic. While this does not invalidate the findings, readers should be aware of potential confirmation bias in study selection and interpretation.
**Publication bias:** HIIT research showing null or negative results may be less likely to be published or cited in a narrative review.
**Population limits:** The safety data comes exclusively from supervised cardiac rehabilitation programs with thorough medical screening. Results do not apply to unsupervised HIIT in untrained individuals.
**No direct comparison of HIIT doses:** The review does not systematically compare different HIIT protocols (e.g., 4×4 min intervals vs 1×1 min sprint) to determine optimal dose.
**Adherence data lacking:** While HIIT is touted as time-efficient, the review does not present data on dropout rates, session attendance, or long-term adherence compared to MICT.
**No cost-benefit analysis:** The higher per-session risk of HIIT (1 event per 23,182 hours vs 1 per 129,456 hours) is noted but not weighed against the potential benefits of greater fitness gains.
Practical takeaways
For someone running their own n=1 experiment:
### What to test (specific intervention and dose)
**Option A: Practical HIIT (moderate-to-high intensity)**
Protocol: 3× per week, 20–25 minutes total per session
Warm-up: 3 minutes easy cycling or jogging
Intervals: 4 × 4 minutes at 80–90% of maximal heart rate (you should be able to speak 2–3 words at a time, but not hold a conversation)
Recovery: 3 minutes of easy cycling or walking between intervals
Cool-down: 3 minutes easy
Equipment: Stationary bike, treadmill, or outdoor running path
**Option B: Sprint-interval training (very high intensity)**
Protocol: 3× per week, 10–15 minutes total per session
Warm-up: 3 minutes easy cycling
Intervals: 8 × 20 seconds "all-out" effort (as hard as you can sustain for 20 seconds)
Recovery: 10 seconds easy cycling between sprints (this is very short — you'll be breathing hard)
Cool-down: 3 minutes easy
Equipment: Stationary bike (preferably with magnetic resistance for safety)
**Option C: Interval walking (low barrier, moderate intensity)**
Protocol: 5× per week, 1 hour per session
Walk at a "fast" pace for 3 minutes (aim for ~69% max heart rate — brisk but sustainable)
Walk at a "slow" pace for 3 minutes (~63% max heart rate)
Repeat for 1 hour total
Equipment: Comfortable walking shoes, heart rate monitor optional
### Minimum meaningful duration
**Fitness improvements (VO₂max):** 6 weeks minimum to see measurable change; 12 weeks for full effect
**Insulin sensitivity and body composition:** 12 weeks minimum
**Blood pressure:** 8–12 weeks
**Safety note:** If you have any cardiovascular risk factors (age >45 for men, >55 for women; smoking; diabetes; high blood pressure; family history of heart disease), get medical clearance before starting HIIT
### What to measure (specific metrics)
**Primary outcome (most sensitive to change):**
**Estimated VO₂max:** Use a submaximal fitness test (e.g., 1-mile walk test, Astrand-Rhyming cycle test, or Cooper 12-minute run test). Measure at baseline, 6 weeks, and 12 weeks. A 10–19% improvement is a positive result.
**Secondary outcomes (measure weekly or biweekly):**
**Resting heart rate:** Measure first thing in the morning before getting out of bed. A decrease of 5–10 bpm over 12 weeks is a positive result.
**Waist circumference:** Measure at the level of the navel, after exhaling. A reduction of 2–5 cm over 12 weeks is a positive result.
**Blood pressure:** Use a validated home monitor. Measure at the same time each day (morning, before medication if applicable). A reduction of 5–10 mmHg systolic is a positive result.
**Perceived exertion:** Rate each session on a 1–10 scale (1 = very easy, 10 = maximal effort). Track whether the same absolute workload feels easier over time.
**Optional (if you have access):**
Fasting blood glucose and HbA1c (via fingerstick or lab test) at baseline and 12 weeks
Body fat percentage (via DXA, bioelectrical impedance, or skinfold calipers)
### Key confounds to control for
**Diet:** Do not change your eating habits during the experiment unless you are specifically testing diet + exercise. Keep a food log for the first week to establish baseline, then maintain consistent intake.
**Sleep:** Poor sleep impairs recovery and blunts training adaptations. Track sleep duration and quality (e.g., via sleep diary or wearable). Aim for 7–9 hours per night.
**Other physical activity:** Keep non-experimental exercise constant. If you normally walk 5,000 steps/day, do not suddenly start walking 10,000 steps/day during the HIIT experiment.
**Stress:** Chronic stress elevates cortisol, which can impair fitness gains and insulin sensitivity. Track perceived stress weekly (e.g., Perceived Stress Scale).
**Time of day:** Train at the same time of day for all sessions. Circadian rhythms affect performance and recovery.
**Hydration and caffeine:** Standardise pre-exercise hydration and caffeine